Entrepreneurship and innovation enable Weill Cornell Medicine to bring discoveries to patients faster.

Weill Cornell Medicine investigators enjoy a robust pipeline of dedicated programs capable of taking early discoveries made in academic labs to U.S. Food and Drug Administration-approved testing in clinical trials. Other new initiatives are designed to foster a culture of entrepreneurship and to build the next generation of leaders in life sciences industries and new ventures. 

Enterprise Innovation

Weill Cornell Medicine Enterprise Innovation engages and collaborates with Weill Cornell Medicine faculty and trainees while fostering alliances with leaders in the biomedical industry and business and investment community.

Dean's Symposium on Entrepreneurship and Academic Drug Development Highlights Weill Cornell Medicine’s Expanding Entrepreneurial Ecosystem

The institution launched Weill Cornell Medicine Enterprise Innovation, a new entity designed to accelerate biomedical innovation to market, translating groundbreaking research.

Dr. Ronald Crystal Elected Fellow of National Academy of Inventors

Dr. Ronald Crystal has been elected a fellow of the National Academy of Inventors.

BioEntrepreneurship Program to Fuel NYS Life Science Startups

Cornell MBA students and life science researchers will be able to immerse themselves in real-world startup projects and get the tools, training and connections to launch life science startups.

Digital Domains: Apps, Video Games and Other Media are Filling Gaps in Mental Healthcare

Apps, video games and other media are filling gaps in mental healthcare.
Views on Innovation
Dr. Augustine M.K. Choi, the Stephen and Suzanne Weiss Dean
We have recently implemented many initiatives to help our faculty translate their research findings into innovative treatments and therapies for our patients.
Dr. John P. Leonard, Senior Associate Dean of Innovation and Initiatives
Getting new innovations across the finish line requires collaboration, often with industry partners, to scale up findings for application in healthcare.
Dr. William Polvino, CEO of Bridge Medicines
Tri-Institutional Therapeutics Discovery Institute and Bridge Medicines put the skill of a pharmaceutical company on the campuses of three great institutions.
Dr. Francis Barany
Dr. Francis Barany, Professor of Microbiology and Immunology
The professionals at Enterprise Innovation possess strong first-hand knowledge of what it takes to start a company.